Subscribe to Email Alerts
INOVIQ
  • About Us
    • About INOVIQ
    • Market Opportunity
    • Board
    • Management
    • Medical & Scientific Advisory Board
    • Partners
    • Distributors
    • Compliance
    • Careers
  • Technology
    • Our Science
    • NETs Platform
    • SubB2M Platform
    • BARD1 Biomarker Technology
    • hTERT ICC Assay
    • Intellectual Property
    • Publications
    • Resources
    • Business Development
  • Products
    • Our Products
    • EXO-NET® Pan-Exosome
      • Product Overview
      • Technical Information
      • Data & Figures
      • Ordering
    • hTERT ICC Test
  • Pipeline
    • Development Pipeline
    • NeuCA15-3 Test
    • NeuCA125 Test
    • EXO-Ovarian Cancer Test
    • Exosome Therapeutics
  • Investors
    • Investor Overview
    • ASX Announcements
    • Annual & Financial Reports
    • Presentations
    • Share Price Information
    • AGM
    • INOVIQ Fact Sheet
    • Corporate Governance
    • Shareholder Services
    • FAQ
    • Analyst Reports
  • News & Events
    • INOVIQ in the News
    • Conferences & Events
  • Contact
    • Contact Us
    • Subscribe to Email Alerts

INOVIQ in the News

Heading &

Sub-heading can be edited through HQI

News & Events > INOVIQ in the News
  • INOVIQ in the News
  • Conferences & Events

INOVIQ in the News

Filter by Year:2025 2024 2023 2022 2021 2020 2018 2017 
21-Dec-2022
Passing of Professor Allan Cripps AO
15-Dec-2022
INOVIQ presents at the MST Access Diagnostics Forum
13-Dec-2022
Stocks of the Hour: Kingwest Resources, Doctor Care Anywhere, INOVIQ
28-Nov-2022
China's lockdown rampage causes lower start to ASX
25-Nov-2022
Lithium stocks falling, Critical Minerals Summit commencing: ASX up 0.29% at noon
16-Nov-2022
The Australian: Lots of milestones expected from INOVIQ in 2023 as it aims to commercialise cancer diagnostics products in the US
13-Oct-2022
The Market Herald: INOVIQ signs agreement with Nicoya Lifesciences to develop SubB2M-based test
13-Oct-2022
Financials keeping the local market in the green: ASX up 0.51% at noon
27-Sep-2022
Stockhead Health & Biotech Investment Guide
8-Sep-2022
INOVIQ carving itself healthy share of multi-billion dollar medical diagnostics market
  • 1
  • 2
  •  Next

Quick Links

Contact Us

Melbourne:
T: +61 3 9548 7586
23 Normanby Road
Notting Hill VIC 3168
Australia

US Office:
987 Old Eagle School Road, Suite 709
Wayne, PA 19087

Online:
E: [email protected]
W: www.inoviq.com

Email Alerts

Subscribe to Email Alerts

Follow Us

Copyright © INOVIQ
Site Map Privacy Search
Site by